Names without a link are companies not yet registered in OpenBizGraph
§05
Network
NETWORK
Loading the relationship graph...
Drag to move · click to open
§06
History
80 EVENTS
Establishment date: August 10, 1964
Saga Plant Completion
Started as a production plant for Pocari Sweat. In 1990, began production of pharmaceutical raw materials.
American Ridge Vineyards joined the Otsuka Group.
Korean Dong-A Foods (now Dong-A Otsuka) joined the Otsuka Group.
Otsuka Pakistan established.
Launch of Amino Levan EN.
Oral nutrition supplement for liver failure.
Launch of Pretaal.
Antiplatelet agent.
Release of the food supplement beverage 'Five Mini'
Completion of Tokushima Wajiki factory
Completion of Takasaki factory
Establishment of Otsuka America and Otsuka America Pharmaceutical
U.S. company Farmabit (now Farmabit LLC) joins the Otsuka Group
First Women's Forum held
Release of 'Mucosta'
Release of 'Elcarlin'
U.S. Crystal Gazer Water Company joins the Otsuka Group
Establishment of Otsu Research Institute (now Otsu Skin Care Research Institute)
Release of 'Aquatum'
Release of U.S.-origin supplement 'Nature Made' in Japan
Release of endurance sports drink 'Energen'
Completion of Fukui factory
Establishment of Kinsha Otsuka in Taiwan
Establishment of Otsuka (Philippines) Pharmaceutical
Establishment of Hong Kong Otsuka Pharmaceutical
Establishment of Kapalindera Otsuka (now Ameltianda Otsuka) in Indonesia
Establishment of Otsuka Pharmaceutical Europe in the UK
U.S. Cambridge Isotope Laboratories joins the Otsuka Group
Completion of Tokushima Itano Factory
Signed a business agreement with Bristol-Myers Squibb (BMS)
Signed a joint development and sales agreement for the antipsychotic drug aripiprazole in the United States and other countries worldwide.
Launch of 'U-Bit'.
Opening of Otsuka Nutrition Product Research Institute (now Nutrition Science Research Institute – Otsuka Research Site).
Establishment of the OIAA (Otsuka International Asia Arab) business division.
Launch of 'ABILIFY' in the United States.
Establishment of Tianjin Otsuka Beverage in China.
Investment in Otsuka (China) and establishment of Otsuka Pharmaceutical R&D (Beijing).
Launch of BCAA supply 'Amino Value'.
Launch of Cosmedics 'Inner Signal'.
Launch of the specific health food 'Sage's Table' (now 'Sage's Table Double Support').
Launch of soy bar 'Soy Joy (SOYJOY)'.
Introduction of corporate symbol.
Recognized under the Next-Generation Development Support Promotion Act for establishing an employment environment that supports work–childcare balance, and received the 2008 Next-Generation Certification Mark (nickname 'Kurumin').
To actively create workplaces for people with both physical and mental disabilities, the company established a special subsidiary 'Heartful Kawachi' in 2011.
Advanced initiatives and achievements to create a workplace conducive to women's employment were recognized, and in 2014 the company received the 'Top 100 Diversity Management Companies' award (Minister of Economy, Trade and Industry).
In 2020, the company was certified as the first business owner under the 'Monisu Certification' system for excellent small and medium-sized enterprises in disability employment.
Continuous efforts in promoting diversity and creating a workplace that is easy for both men and women to work in were recognized, and the company received the 'Grand Prize' at the 2020 (Reiwa 1) Tokyo Metropolitan Women's Empowerment Award.
100th anniversary of the Otsuka Group founding.
Launch of 'Ajobi' in Japan.
UCLA company joins the Otsuka Group.
Support for women's urogenital health.
Launch of 'Tokoe' to gently support premenstrual changes in women.
Launch of 'Moizelt' in Japan.
Samutas launched in Japan
Start providing FACEDUO (Face Duo)
Osaka Drug Discovery Research Center established
Cosmedix 'Sakuraé' released
Obtained manufacturing and sales approval for 'ABILIFY ASIMTUFII' in the United States
Obtained additional indication approval for 'Lexalt' for agitation associated with Alzheimer's disease in the United States
Mindset Inc. of the United States joins the Otsuka Group
Established Arab Otsuka Nutraceuticals in Egypt
Signed a collaboration agreement on the first heatstroke countermeasure promotion by the Ministry of the Environment
Bonafide Health Inc. of the United States joins the Otsuka Group
Research, development, manufacturing, and sales of health foods for women
The company's LGBTQ+ initiatives were recognized, earning a 'Silver' rating in the PRIDE Index 2023.
Launch of 'Rejoyn™' in the United States
Obtained additional indication approval for 'Lexalt' for agitation associated with Alzheimer's disease in Japan
Jnana Therapeutics Inc. of the United States joins the Otsuka Group
Established Otsuka Nutraceutical India in India
Rupkinase released in Japan
Launch of the food education game app 'Mogu Mogu Town'
Launch of nutrition monitoring service 'Vivoo' in Japan
Release of 'Milevo'
Release of 'Hemsite'
Release of Nexetol tablets
Release of VOYXACT® in the United States
Release of DawnzeraTM in Europe
Release of self-conditioning food '/zeroz (Zeroz)'
§07
News
4 ARTICLES
Caution about suspicious emails posing as executives
Since August 2026, suspicious emails claiming to be the president of our company or group companies have been reported. The emails may contain business proposals, but they are unrelated to our company. If received, you are advised not to reply, provide money, or personal information.
Otsuka Group's Multi‑Stakeholder Policy
The Otsuka Group aims to create a well‑being future through collaboration with employees, patients, business partners, society, and shareholders. With a policy of appropriately distributing the results generated by co‑creation of value and productivity improvement, we work on sustainable returns through employee development, environmental improvement, wage increases, and education and training.
Beware of malicious fake sites
Otsuka Pharmaceutical has announced that it has identified fake sites posing as its product retailers or using its company name and product names without permission for event announcements. Using such sites can lead to goods not arriving, counterfeit products being sent, or misuse of money and personal information, potentially causing harm. The company urges caution when purchasing products or attending events, and if you become a victim, to contact the Consumer Hotline (188). If you find a suspicious site, consult the Consumer Affairs Agency or the local police station.
Beware of counterfeit 'Equel Pouch 120 tablets'
We have confirmed that counterfeit 'Equel Pouch 120 tablets' are being traded on some internet sales sites. The designated sales routes are face‑to‑face sales at hospitals, clinics, and pharmacies, and the official online store "Ootsuka Plus One"; the quality and safety of products purchased through other routes are not guaranteed. Products purchased through the designated sales routes and those currently on sale have no issues, and we are proceeding with measures including providing information to relevant authorities and legal actions against the manufacturers and sellers of counterfeit products.